Furthermore, HER2 and/or HER3 are upregulated in many tumor cells, such as CRC and gastric cancer cells [9, 22]; overexpression of these EGFR-family proteins has concordance with resistance, metastasis, and poor prognosis of various cancers [11, 22]. Here, ERBB3 is linked to cancer.